Share this postSnowball ResearchNano-cap company, Ocuphire Pharma (OCUP), appoints an interim CEO who previously co-founded and served as CFO of a pharmaceutical firm acquired by GSK for $5.1 billion (Ultra short notes)Copy linkFacebookEmailNotesMoreNano-cap company, Ocuphire Pharma (OCUP), appoints an interim CEO who previously co-founded and served as CFO of a pharmaceutical firm acquired by GSK for $5.1 billion (Ultra short notes)Apr 26, 2024∙ PaidShare this postSnowball ResearchNano-cap company, Ocuphire Pharma (OCUP), appoints an interim CEO who previously co-founded and served as CFO of a pharmaceutical firm acquired by GSK for $5.1 billion (Ultra short notes)Copy linkFacebookEmailNotesMoreShareOcuphire Pharma (OCUP)233KB ∙ PDF fileDownloadDownload This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext